Notably, in NASH, intestinal hyper-permeability, systemic/portal endotoxemia, and systemic/intestinal/MAT inflammation are initiated by TNFα-released from activated immune cells [2,4,5, 7,9,10]. Here, TNF is linked to metabolic dysfunction-associated steatohepatitis.